
Sensient Technologies Corporation Financial Ratios 2025-2007 | SXT
Brief overview of Sensient Technologies Corporation's valuation and returns
The comparison uses the five latest available annual observations between 2021 and 2025.
The valuation comparison uses P/E 29.23x (median 28.96x), EV/EBITDA 15.23x (median 17.23x), P/S 2.44x (median 2.25x). On average, multiples differ from their five-year medians by only +7.4%. Valuation is near its familiar historical range.
The inverse P/E implies an earnings yield of 3.4%. This is not a dividend yield, but current earnings relative to market price.
The latest available business-quality ratios are ROE 11.3%, ROA 6%, ROCE 17.4%. Return ratios are at workable levels. The business generates positive returns, though efficiency is not exceptional.
PEG is 4.49x. Price is well ahead of embedded growth, making market expectations demanding.
The cash conversion cycle lengthened from 175.9 days to 237.7 days, or 61.8 days. More cash is tied up in operations.
Valuation takeaway
Sensient Technologies Corporation's multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.
Annual Financial Ratios Sensient Technologies Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
29.2 | 23.8 | 29.9 | 22.9 | 29.0 | 29.4 | 31.5 | 16.8 | 35.6 | 27.0 | 25.7 | 40.2 | - | 15.3 | 16.4 | 12.5 | 13.2 | 16.6 | - |
P/S |
2.4 | 1.9 | 1.9 | 2.2 | 2.5 | 2.4 | 2.0 | 1.9 | 2.3 | 2.5 | 2.0 | 2.0 | - | 1.3 | 1.4 | - | - | - | - |
EPS |
3.2 | 3.0 | 2.2 | 3.4 | 2.8 | 2.6 | 1.9 | 3.7 | 2.0 | 2.8 | 2.3 | 1.5 | 2.3 | 2.5 | 2.4 | 2.2 | 1.8 | 1.9 | - |
EV (Enterprise Value) |
3.89 B | 2.94 B | 2.76 B | 3.21 B | 3.41 B | 3.19 B | 3.43 B | 3.58 B | 4.03 B | 4.22 B | 3.59 B | 3.66 B | 3.23 B | 2.5 B | 2.56 B | 1.32 B | 1.13 B | 1.5 B | -10.5 M |
EBITDA per Share |
6.35 | 5.98 | 5.06 | 5.95 | 5.28 | 4.78 | 4.17 | 6.05 | 4.94 | 5.22 | 4.67 | 3.75 | - | 4.83 | 4.76 | 4.44 | 3.91 | 4.32 | - |
EV/EBITDA |
14.5 | 11.7 | 13.0 | 12.9 | 15.2 | 17.2 | 18.1 | 13.0 | 17.5 | 17.1 | 15.7 | 18.7 | - | 9.3 | 9.7 | 6.1 | 6.0 | 7.3 | - |
PEG |
4.49 | 2.9 | -18.1 | 3.93 | 13.08 | 11.7 | -0.66 | 0.21 | -1.28 | 1.23 | 0.48 | -1.21 | - | 4.63 | 1.49 | - | - | - | - |
P/B |
1.8 | 1.5 | 1.4 | 1.6 | 2.0 | 1.8 | 2.9 | 3.1 | 3.7 | 4.1 | 3.2 | 2.8 | 2.2 | 1.6 | 1.9 | 0.8 | 0.7 | - | - |
P/CF |
30.7 | 18.9 | 16.4 | 267.8 | 23.7 | 14.7 | 18.7 | 80.7 | 25.7 | 24.1 | 56.9 | 27.0 | - | 53.3 | 27.9 | 8.6 | 8.2 | 17.4 | - |
ROE % |
11.27 | 11.75 | 8.87 | 14.09 | 12.65 | 11.72 | 9.31 | 18.30 | 10.51 | 15.11 | 12.64 | 7.03 | - | 10.74 | 11.48 | 10.89 | 9.53 | - | - |
ROA % |
5.99 | 6.16 | 4.64 | 7.11 | 6.80 | 6.29 | 4.71 | 8.62 | 5.20 | 7.57 | 6.24 | 4.17 | - | 6.97 | 7.28 | 6.70 | 5.44 | - | - |
ROCE % |
17.35 | 18.06 | 14.72 | 19.68 | 18.12 | 16.34 | 7.87 | 12.63 | 11.13 | 12.76 | 11.10 | 8.48 | - | 12.16 | 13.19 | 17.75 | 16.17 | - | - |
Current Ratio |
- | - | - | - | - | - | 3.9 | 3.8 | 3.4 | 3.4 | 3.5 | 3.4 | 3.3 | 3.7 | 3.4 | - | - | - | - |
DSO |
67.4 | 65.9 | 72.0 | 71.5 | 65.5 | 61.3 | 58.8 | 67.2 | 52.4 | 51.3 | 61.6 | 57.7 | - | 59.4 | 56.0 | - | - | - | - |
DIO |
217.5 | 208.3 | 213.0 | 187.9 | 156.4 | 161.5 | 169.8 | 194.6 | 190.8 | 162.6 | 162.1 | 171.0 | - | 162.3 | 154.2 | - | - | - | - |
DPO |
47.2 | 47.0 | 50.1 | 51.6 | 45.9 | 40.6 | 38.0 | 52.3 | 45.2 | 37.2 | 37.8 | 37.7 | - | 35.3 | 34.9 | - | - | - | - |
Operating Cycle |
284.9 | 274.2 | 284.9 | 259.4 | 221.8 | 222.8 | 228.7 | 261.8 | 243.2 | 213.9 | 223.6 | 228.7 | - | 221.7 | 210.2 | - | - | - | - |
Cash Conversion Cycle |
237.7 | 227.3 | 234.8 | 207.8 | 175.9 | 182.2 | 190.6 | 209.5 | 198.0 | 176.7 | 185.8 | 191.0 | - | 186.4 | 175.3 | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sensient Technologies Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.21 | 1.04 | 0.87 | 0.89 | 0.82 | 0.78 | 0.73 | 0.73 | 0.75 | 0.81 | 0.8 | - | 0.86 | 0.92 | 0.89 | - | 0.81 | 0.62 | 0.75 | - | 0.78 | 0.72 | 0.49 | - | 0.75 | 0.81 | 0.78 | - | 1.12 | 0.93 | 0.89 | - | 0.74 | 0.7 | 0.3 | - | 0.8 | 0.63 | 0.7 | - | 0.61 | 0.64 | 0.65 | - | 0.44 | 0.6 | -0.04 | - | 0.63 | 0.65 | 0.43 | - | 0.66 | 0.7 | 0.58 | - | 0.64 | 0.67 | 0.53 | 0.59 | 0.58 |
EBITDA per Share |
2.19 | 1.95 | 1.73 | 1.73 | 1.63 | 1.57 | 1.53 | 1.52 | - | - | 1.55 | - | 2.07 | 1.32 | 1.57 | - | 2.04 | 0.85 | 1.41 | - | 1.84 | 1.58 | 1.11 | - | 1.9 | 1.78 | 1.49 | - | 2.11 | 1.85 | 1.59 | - | 2.03 | 1.56 | 0.82 | - | 1.94 | 1.5 | 1.32 | - | 1.75 | 1.5 | 1.25 | - | 1.58 | 1.56 | 0.44 | - | 1.77 | 1.5 | 0.99 | - | 1.76 | 1.59 | 1.18 | - | 1.71 | 1.56 K | 1.11 | 0.97 | 0.96 |
ROE % |
14.08 | 13.15 | 12.55 | 12.35 | 12.01 | 11.84 | 12.04 | 12.39 | 13.26 | 14.31 | 14.93 | 11.66 | 15.27 | 14.24 | 13.63 | 9.78 | 13.30 | 12.97 | 12.44 | 9.02 | 12.64 | 13.01 | 13.45 | 11.23 | 16.72 | 17.65 | 18.20 | 14.48 | 18.26 | 16.38 | 13.38 | 8.94 | 13.20 | 12.78 | 12.90 | 11.36 | 14.62 | 13.84 | 14.09 | 10.36 | 12.40 | 11.91 | 8.22 | 4.61 | 7.15 | 7.71 | 6.66 | 6.86 | 9.71 | 10.20 | 10.10 | 8.38 | 11.43 | 11.77 | 11.26 | 8.76 | 11.79 | 12.00 | 2.52 | 3.03 | 3.26 |
ROA % |
7.47 | 6.96 | 6.62 | 6.50 | 6.34 | 6.26 | 6.33 | 6.44 | 6.86 | 7.36 | 7.66 | 5.99 | 7.52 | 5.56 | 7.40 | 5.33 | 7.22 | 7.02 | 6.68 | 4.84 | 6.67 | 6.76 | 6.88 | 5.69 | 8.28 | 8.59 | 8.71 | 6.82 | 8.69 | 7.89 | 6.51 | 4.42 | 6.55 | 6.37 | 6.46 | 5.69 | 7.31 | 6.90 | 7.01 | 5.14 | 6.35 | 6.37 | 4.53 | 2.74 | 4.42 | 4.94 | 4.44 | 4.56 | 6.41 | 6.69 | 6.59 | 5.44 | 7.38 | 7.55 | 7.18 | 5.56 | 7.39 | 7.35 | 1.60 | 1.83 | 1.90 |
ROCE % |
21.44 | 20.24 | 19.44 | 19.25 | 18.90 | 18.22 | 18.44 | 18.69 | 19.02 | 20.57 | 21.17 | 16.23 | 21.22 | 20.03 | 19.34 | 13.85 | 18.26 | 17.77 | 17.68 | 12.61 | 17.01 | 17.98 | 19.08 | 15.38 | 21.22 | 22.89 | 23.99 | 18.39 | 24.49 | 23.85 | 20.60 | 14.13 | 20.25 | 19.37 | 19.85 | 17.03 | 22.15 | 21.36 | 21.63 | 15.94 | 19.39 | 19.03 | 14.51 | 9.02 | 12.97 | 13.44 | 11.61 | 10.79 | 15.19 | 15.94 | 16.05 | 13.13 | 17.89 | 18.67 | 18.12 | 14.09 | 19.04 | 19.65 | 4.16 | 4.95 | 5.36 |
DSO |
71.0 | 69.7 | 72.8 | 71.5 | 71.8 | 71.8 | 69.4 | 69.2 | 73.4 | 74.8 | 76.0 | - | 36.3 | 34.6 | 69.7 | - | 69.2 | 70.1 | 62.3 | - | 66.0 | 66.1 | 58.2 | - | 61.2 | 57.4 | 61.5 | - | 68.0 | 64.2 | 57.7 | - | 49.3 | 51.3 | 50.8 | - | 49.5 | 47.7 | 55.1 | - | 59.8 | 59.4 | 58.9 | - | 55.3 | 54.2 | 55.6 | - | 55.0 | - | 56.6 | - | 56.4 | - | - | - | - | - | - | - | - |
DIO |
220.9 | 215.2 | 214.6 | 204.7 | 206.5 | 197.4 | 187.6 | 204.3 | 214.3 | 210.3 | 212.5 | - | 95.6 | 80.2 | 165.1 | - | 149.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
40.9 | 38.2 | 41.2 | 39.0 | 40.2 | 39.4 | 35.5 | 38.1 | 42.0 | 43.5 | 49.2 | - | 25.3 | 21.8 | 47.5 | - | 47.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 284.9 | 287.3 | 276.2 | 278.2 | 269.1 | 257.1 | 273.4 | 287.8 | 285.1 | 288.5 | - | 131.9 | 114.8 | 234.8 | - | 219.0 | 70.1 | 62.3 | - | 66.0 | 66.1 | 58.2 | - | 61.2 | 57.4 | 61.5 | - | 68.0 | 64.2 | 57.7 | - | 49.3 | 51.3 | 50.8 | - | 49.5 | 47.7 | 55.1 | - | 59.8 | 59.4 | 58.9 | - | 55.3 | 54.2 | 55.6 | - | 55.0 | - | 56.6 | - | 56.4 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 246.7 | 246.2 | 237.2 | 238.0 | 229.7 | 221.6 | 235.3 | 245.8 | 241.5 | 239.2 | - | 106.5 | 93.0 | 187.2 | - | 171.3 | 70.1 | 62.3 | - | 66.0 | 66.1 | 58.2 | - | 61.2 | 57.4 | 61.5 | - | 68.0 | 64.2 | 57.7 | - | 49.3 | 51.3 | 50.8 | - | 49.5 | 47.7 | 55.1 | - | 59.8 | 59.4 | 58.9 | - | 55.3 | 54.2 | 55.6 | - | 55.0 | - | 56.6 | - | 56.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Sensient Technologies Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.